Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,629 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients.
Thomas D, McDonald VM, Stevens S, Harvey ES, Baraket M, Bardin P, Bowden JJ, Bowler S, Chien J, Chung LP, Gillman A, Hew M, Hodge S, James A, Jenkins C, Katelaris CH, Katsoulotos GP, Langton D, Lee J, Marks G, Peters M, Radhakrishna N, Reynolds PN, Rimmer J, Sivakumaran P, Upham JW, Wark P, Yang IA, Gibson PG. Thomas D, et al. Allergy. 2024 Feb;79(2):384-392. doi: 10.1111/all.15867. Epub 2023 Aug 25. Allergy. 2024. PMID: 37632144
Mepolizumab and Oral Corticosteroid Stewardship: Data from the Australian Mepolizumab Registry.
Thomas D, Harvey ES, McDonald VM, Stevens S, Upham JW, Katelaris CH, Kritikos V, Gillman A, Harrington J, Hew M, Bardin P, Peters M, Reynolds PN, Langton D, Baraket M, Bowden JJ, Bowler S, Chien J, Chung LP, Farah CS, Grainge C, Jenkins C, Katsoulotos GP, Lee J, Radhakrishna N, Reddel HK, Rimmer J, Sivakumaran P, Wark PAB, Gibson PG. Thomas D, et al. J Allergy Clin Immunol Pract. 2021 Jul;9(7):2715-2724.e5. doi: 10.1016/j.jaip.2021.01.028. Epub 2021 Feb 3. J Allergy Clin Immunol Pract. 2021. PMID: 33545399
Gefapixant for chronic cough.
Thomas D, Gibson PG. Thomas D, et al. Lancet. 2022 Mar 5;399(10328):886-887. doi: 10.1016/S0140-6736(21)02438-7. Lancet. 2022. PMID: 35248173 No abstract available.
Asthma remission: what is it and how can it be achieved?
Thomas D, McDonald VM, Pavord ID, Gibson PG. Thomas D, et al. Eur Respir J. 2022 Nov 3;60(5):2102583. doi: 10.1183/13993003.02583-2021. Print 2022 Nov. Eur Respir J. 2022. PMID: 35361633 Free PMC article. Review.
Comorbidities Modify the Phenotype but Not the Treatment Effectiveness to Mepolizumab in Severe Eosinophilic Asthma.
Kritikos V, Harvey ES, Stevens S, Katelaris CH, Langton D, Rimmer J, Farah CS, Gillman A, Hew M, Radhakrishna N, Thomas D, Gibson PG; Australian Mepolizumab Registry Investigators. Kritikos V, et al. Among authors: thomas d. J Allergy Clin Immunol Pract. 2023 Mar;11(3):885-895.e13. doi: 10.1016/j.jaip.2022.12.004. Epub 2022 Dec 23. J Allergy Clin Immunol Pract. 2023. PMID: 36572182
Realignment of clinical research after the COVID-19 era.
Thomas D, McDonald VM, Gibson PG. Thomas D, et al. Lancet Respir Med. 2024 Apr 10:S2213-2600(24)00080-8. doi: 10.1016/S2213-2600(24)00080-8. Online ahead of print. Lancet Respir Med. 2024. PMID: 38614105 No abstract available.
10,629 results
You have reached the last available page of results. Please see the User Guide for more information.